Sulochana S Bhandarkar

Summary

Affiliation: Emory University
Country: USA

Publications

  1. doi request reprint Quality of life measures for acne patients
    Lauren E Barnes
    Department of Dermatology, Center for Dermatology Research, Wake Forest School of Medicine, Box 2473, Medical Center Boulevard, Winston Salem, NC 27157 1071, USA
    Dermatol Clin 30:293-300, ix. 2012
  2. doi request reprint Quality-of-life issues in vitiligo
    Sulochana S Bhandarkar
    Department of Dermatology, School of Medicine, Emory University, 1315 Clifton Road, Atlanta, GA 30322, USA
    Dermatol Clin 30:255-68, viii. 2012
  3. ncbi request reprint Curcumin as an inhibitor of angiogenesis
    Sulochana S Bhandarkar
    Department of Dermatology, Emory University School of Medicine, Winship Cancer Institute, Atlanta, GA 30322, USA
    Adv Exp Med Biol 595:185-95. 2007
  4. pmc Fulvene-5 potently inhibits NADPH oxidase 4 and blocks the growth of endothelial tumors in mice
    Sulochana S Bhandarkar
    Department of Dermatology and Atlanta Veterans Administration Medical Center, Emory University, Atlanta, Georgia 30322, USA
    J Clin Invest 119:2359-65. 2009
  5. ncbi request reprint Angiogenesis in cutaneous lesions of leprosy: implications for treatment
    Sulochana S Bhandarkar
    Department of Dermatology, Emory University School of Medicine, WMB 5309, 1639 Pierce Dr, Atlanta, GA 30322, USA
    Arch Dermatol 143:1527-9. 2007
  6. doi request reprint Targeted therapy of oral hairy leukoplakia with gentian violet
    Sulochana S Bhandarkar
    Department of Dermatology, Emory University School of Medicine, Atlanta, Georgia 30322, USA
    J Am Acad Dermatol 58:711-2. 2008
  7. doi request reprint Tris (dibenzylideneacetone) dipalladium, a N-myristoyltransferase-1 inhibitor, is effective against melanoma growth in vitro and in vivo
    Sulochana S Bhandarkar
    Department of Dermatology, Emory University School of Medicine, Atlanta, GA 30322, USA
    Clin Cancer Res 14:5743-8. 2008

Collaborators

Detail Information

Publications7

  1. doi request reprint Quality of life measures for acne patients
    Lauren E Barnes
    Department of Dermatology, Center for Dermatology Research, Wake Forest School of Medicine, Box 2473, Medical Center Boulevard, Winston Salem, NC 27157 1071, USA
    Dermatol Clin 30:293-300, ix. 2012
    ..The ideal HRQOL measure for the management of patients with acne is a concise questionnaire that places minimal burden on respondents and allows physicians to track improvement in HRQOL with successful treatment...
  2. doi request reprint Quality-of-life issues in vitiligo
    Sulochana S Bhandarkar
    Department of Dermatology, School of Medicine, Emory University, 1315 Clifton Road, Atlanta, GA 30322, USA
    Dermatol Clin 30:255-68, viii. 2012
    ..Many instruments, both dermatology specific and dermatology nonspecific, have been used to measure HRQL. Assessing HRQL in vitiligo is an important part of disease management...
  3. ncbi request reprint Curcumin as an inhibitor of angiogenesis
    Sulochana S Bhandarkar
    Department of Dermatology, Emory University School of Medicine, Winship Cancer Institute, Atlanta, GA 30322, USA
    Adv Exp Med Biol 595:185-95. 2007
    ..Curcumin's effect on the overall process of angiogenesis compounds its enormous potential as an antiangiogenic drug...
  4. pmc Fulvene-5 potently inhibits NADPH oxidase 4 and blocks the growth of endothelial tumors in mice
    Sulochana S Bhandarkar
    Department of Dermatology and Atlanta Veterans Administration Medical Center, Emory University, Atlanta, Georgia 30322, USA
    J Clin Invest 119:2359-65. 2009
    ..In conclusion, the present study establishes Nox4 as a critical regulator of hemangioma growth and identifies fulvenes as a potential class of candidate inhibitor to therapeutically interfere with Nox function...
  5. ncbi request reprint Angiogenesis in cutaneous lesions of leprosy: implications for treatment
    Sulochana S Bhandarkar
    Department of Dermatology, Emory University School of Medicine, WMB 5309, 1639 Pierce Dr, Atlanta, GA 30322, USA
    Arch Dermatol 143:1527-9. 2007
    ..To examine the potential role of angiogenesis in leprosy...
  6. doi request reprint Targeted therapy of oral hairy leukoplakia with gentian violet
    Sulochana S Bhandarkar
    Department of Dermatology, Emory University School of Medicine, Atlanta, Georgia 30322, USA
    J Am Acad Dermatol 58:711-2. 2008
    ..The application of gentian violet can be used as a method to OHL treatment. Gentian violet is an inexpensive and safe therapy and, given that it inhibits reactive oxygen, this old therapy is now a targeted novel therapy...
  7. doi request reprint Tris (dibenzylideneacetone) dipalladium, a N-myristoyltransferase-1 inhibitor, is effective against melanoma growth in vitro and in vivo
    Sulochana S Bhandarkar
    Department of Dermatology, Emory University School of Medicine, Atlanta, GA 30322, USA
    Clin Cancer Res 14:5743-8. 2008
    ..Studies were carried out to determine the mechanism of action of Tris DBA...